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Normal human epidermal keratinocytes (NHEK) grown
in serum-free medium on a plastic substrate spontane-
ously differentiate at high cell densities in vitro. Because
protein kinase C (PKC) regulates murine keratinocyte
differentiation triggered by a variety of stimuli, we
examined the role of this signaling pathway in density-
dependent activation of NHEK differentiation. Relative
to subconfluent cultures, confluent NHEK expressed
markedly higher levels of multiple differentiation markers
assayed by immunoblotting, including keratin 1, loricrin,
filaggrin, involucrin, TGK, and SPR-1. Expression of
several of these markers continued to increase for several
days after cells reached confluency. The total level of
several PKC isoforms was not substantially altered in
NHEK harvested at different cell densities, based on
Normal epidermis consists of four cellular compartmentsthat are defined by the expression of specific sets ofkeratinocyte differentiation markers occurring in astep-wise manner. For example, the transcripts forkeratins K5 and K14 are expressed in the basal cell
compartment, whereas K1 and K10 are induced in the spinous
compartment; loricrin and filaggrin are first expressed in the granular
compartment; and anucleate cornified cell envelopes comprise the
most superficial cornified layer. The ability to induce many aspects of
epidermal differentiation in cultured keratinocytes has facilitated analysis
of the molecular regulation of keratinocyte-specific gene expression,
as well as the role of intermediary signaling pathways in triggering this
process (Yuspa, 1994).
Primary keratinocytes obtained from newborn mice can be main-
tained as a basal cell-like population by growing them in medium
containing a reduced Ca21 concentration (0.05 mM). Terminal differ-
entiation, characterized by the sequential appearance of spinous followed
by granular cell differentiation markers, is induced by raising the Ca21
to 0.12 mM (Yuspa et al, 1989). The activation of protein kinase C
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immunoblotting; however, subcellular fractionation
revealed that PKCa underwent a redistribution to the
particulate fraction in confluent and postconfluent NHEK
cultures, suggesting that this isozyme was activated under
these conditions and may be involved in triggering
the terminal differentiation program. Supporting this
concept, inhibition of PKC function using bryostatin 1
or GF 109203X blocked the induction of keratinocyte
differentiation markers at high cell densities. These data
suggest that endogenous activation of PKC is responsible
for cell density-mediated stimulation of NHEK differ-
entiation, establishing a critical role for this pathway
in regulating human as well as murine keratinocyte
differentiation. Key words: bryostatin/filaggrin/involucrin/
keratins/loricrin/SPR-1. J Invest Dermatol 111:762–766, 1998
(PKC) is essential for the regulation of genes involved in Ca21-induced
mouse epidermal keratinocyte differentiation, because PKC inhibitors
block differentiation-specific gene induction and PKC activators induce
differentiation markers (Dlugosz and Yuspa, 1993, 1994). Furthermore,
the subcellular distribution of PKCα, PKCδ, and PKCε is altered in
differentiating keratinocytes, suggesting that they are activated during
this process (Denning et al, 1995). In vivo, PKCη is selectively expressed
in the granular cell compartment, and the abundance of this isoform
also increases in both the membrane and the cytosol fractions in
differentiating keratinocytes in vitro (Koizumi et al, 1993; Denning et al,
1995). In cultures of differentiating keratinocytes, both intracellular
diacylglycerol, an endogenous PKC activator, and free Ca21 increase,
suggesting a mechanism that may lead to PKC activation (Tang et al,
1988; Sharpe et al, 1989; Kruszewski et al, 1991; Lee and Yuspa, 1991;
Punnonen et al, 1993). Direct evidence that PKC regulates the
expression of markers of differentiation comes from studies with a PKCα
anti-sense oligonucleotide that reduces or prevents the expression of
granular cell proteins in mouse keratinocytes induced to differentiate
by Ca21 (Lee et al, 1997). The α isoform of PKC was also implicated
as an essential regulator of marker expression using isoform-selective
pharmacologic PKC inhibitors (Denning et al, 1995).
The same complement of PKC isoforms is detected in both mouse
and human keratinocytes (Osada et al, 1990; Dlugosz et al, 1992;
Gherzi et al, 1992; Matsui et al, 1992; Fisher et al, 1993), suggesting
that individual isoforms will have similar functions in the skin of both
species. In fact, the prevailing evidence indicates that PKC is activated
in differentiating human keratinocytes and regulates expression of
certain suprabasal markers (Ueda et al, 1996; Gherzi et al, 1992; Matsui
et al, 1992), but a comprehensive analysis of this relationship is lacking.
Because changes in PKC have been detected in human skin diseases
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(Fisher et al, 1993; Koizumi et al, 1993; Rasmussen and Celis, 1993),
an understanding of the functional contribution of specific PKC
isozymes to the regulation of human epidermal physiology is
important for the identification of potential therapeutic targets for
PKC inhibitors or activators. Furthermore, human keratinocytes in
culture can be induced to differentiate by manipulating the cell density
(Pillai et al, 1990; Hohl et al, 1991; Poumay and Pittelkow, 1995), and
this could provide additional insights beyond the information obtained
from mouse keratinocytes induced to differentiate by Ca21, because
PKC α is calcium dependent and might be activated unnaturally in
the mouse system. In this report we examine the role of PKC in the
expression of differentiation markers in human keratinocytes obtained
from adult and neonatal skin and induced to differentiate in culture
by manipulating the cell density. The results reveal the crucial
importance of PKC activation in marker expression and support a
particularly influential contribution of PKCα.
MATERIALS AND METHODS
Reagents Bryostatin 1 was obtained from the Pharmaceutical Resources
Branch of the National Cancer Institute and LC Laboratories (Woburn, MA)
and GF109203X was purchased from Calbiochem (La Jolla, CA). All reagents
were dissolved in dimethylsulfoxide and stored at –20°C.
Cell culture Human breast-derived adult keratinocytes and foreskin-derived
neonatal keratinocytes were purchased from Clonetics (San Diego, CA), and
were grown as submerged cultures on plastic dishes (Falcon Labware, Oxford,
CA) in modified MCDB 153 medium (KGM, GIBCO BRL, Gaithersburg,
MD) containing 0.09 mM Ca21, epidermal growth factor (5 ng per ml), and
bovine pituitary extract (50 µg per ml). After the cells attained 50% confluence,
the medium was changed to 0.09 mM Ca21 containing KGM without epidermal
growth factor and BPE.
Cell fractionation Cells were washed once with ice-cold phosphate-
buffered saline and scraped into PKC lysis buffer [20 mM Tris-HCI (pH 7.5),
5 mM ethylenediamine tetraacetic acid, 0.25 mM phenylmethylsulfonylfluoride,
40 µg leupeptin per ml]. After brief sonication, the lysate was centrifuged at
100,000 3 g for 1 h, and the supernatant was taken as the soluble fraction.
The pellet was resuspended in PKC lysis buffer containing 1% Triton X-100,
centrifuged as before, and the supernatant was removed for the particulate
fraction. Cell fractionation was performed in the presence of the divalent cation
chelator ethylenediamine tetraacetic acid to avoid the effect of elevated Ca21
on membrane partitioning of PKC during the fractionation procedure (Phillips
et al, 1989; Stabel and Parker, 1991). Protein concentration was determined by
the Bio-Rad protein assay.
Western blots For total sodium dodecyl sulfate lysates, the cells were washed
twice with ice-cold phosphate-buffered saline and scraped into sodium dodecyl
sulfate sample buffer (Laemmli, 1970), boiled, and run immediately on polyacryl-
amide gels. For soluble and particulate PKC lysates, 30 µg of each protein
fraction was loaded per lane. Proteins were transferred to nitrocellulose
electrophoretically, and the membranes were blocked in 5% milk in tris-buffered
saline. For detection of PKC isozymes, the membranes were incubated with
anti-PKC antibodies specific for the catalytic subunit of PKCα at a dilution of
1:500 (Upstate Biotechnology, Lake Placid, NY), PKCδ and PKCη at a 1:100
dilution (Santa Cruz Biotechnology, Santa Cruz, CA), and PKCε at a dilution
of 1:1000 (GIBCO BRL, Gaithersburg, MD). Human filaggrin and involucrin
were used at 1:200 (Biomedical Technology, Stoughton MA), c-terminal human
transglutaminase K (TGK) antibody was a gift from Dr. Robert Rice (University
of California, Davis, CA), and K1, K14, loricrin, and SPR-1 were detected
with antibodies described previously (Roop et al, 1985; Denning et al, 1995;
Kartasova et al, 1996). Proteins were detected using the ECL system (Amersham,
Arlington Heights, IL) with horseradish peroxidase-conjugated secondary anti-
body (Bio-Rad, Hercules, CA) at a 1:5000 dilution. All PKC antibodies were
isozyme specific as determined by the lack of cross-reactivity to purified
recombinant PKC isozymes isolated from a baculovirus expression system.
RESULTS
Increasing cell density upregulates expression of multiple differ-
entiation markers in cultured human keratinocytes The expres-
sion of markers characteristic of spinous and granular cell differentiation
was evaluated in low-passage adult and neonatal normal human
epidermal keratinocytes (NHEK) cultures at three cell densities:
preconfluent (µ70%–80% confluent), confluent, and postconfluent
(three additional days after reaching confluence). Confluency was
Figure 1. Cell density induces expression of multiple keratinocyte-
specific differentiation markers in cultured NHEK. Keratinocytes isolated
from either adult or neonatal human skin were analyzed when 70%–80%
confluent, 100% confluent, and 3 d postconfluent. Polyacrylamide gel
electrophoresis, transfer to nitrocellulose, and immunoblotting were performed
using total cells lysates as described in Materials and Methods. Note density-
dependent upregulation of spinous and granular cell differentiation markers,
with little effect on the abundance of the basal cell keratin K14. The nature of
the higher molecular weight band in differentiating keratinocytes detected using
SPR-1 antibody is unknown.
asssociated with increased expression of all the granular cell markers
examined in both neonatal and adult cells (Fig 1) and in most cases,
expression increased further in the postconfluent state (note SPR-1,
filaggrin, loricrin, and involucrin). Confluency in this study appeared
to influence the spinous marker K1, as reported previously (Poumay
and Pittelkow, 1995; Pillai et al, 1990), whereas K14, a basal cell
keratin, was not altered by confluency (Fig 1). Although similar results
were obtained with both adult and neonatal cells, marker expression
generally occurred earlier in confluency in adult keratinocyte cultures
than in neonatal cells.
Increasing cell density is associated with selective translocation
of PKCa to the particulate fraction in cultured human
keratinocytes Additional studies were performed to determine
whether confluency-mediated keratinocyte differentiation was associ-
ated with alterations in the abundance or distribution of specific PKC
isoforms. Major changes in the total levels of PKCδ, PKCε, or PKCη
were not observed when comparing preconfluent, confluent, and
postconfluent keratinocyte cultures, although a modest increase in
PKCα levels was detected (Fig 2). More significantly, fractionation of
keratinocytes revealed the appearance of PKCα in particulate fractions
of confluent and postconfluent, but not subconfluent cultures (Fig 3).
Because activation of PKCα is associated with translocation from the
cytosol to plasma membrane, these findings suggest that density-
mediated keratinocyte differentiation is associated with endogenous
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Figure 2. Increased cell density is not associated with major changes in
the abundance of PKC isoforms in cultured NHEK. Immunoblot analysis
was performed using Triton X-100 lysates prepared from newborn and adult
NHEK at different stages of confluency. The expression level of PKC isozymes
was determined using isozyme-specific antibodies as described in Materials
and Methods.
Figure 3. PKCa accumulates in the particulate fraction of NHEK
growing at increased cell densities. Soluble and particulate protein fractions
were prepared from keratinocytes at different cell densities as described in
Materials and Methods. The expression level of PKC isozymes in these two
compartments was assessed by immunoblotting.
activation of this PKC isoform. The modest level of PKCα detected
in the particulate fraction is entirely consistent with a physiologic
activation event, illustrated by the modest translocation of PKCα also
detected in mouse epidermal keratinocytes induced to terminally
differentiate with Ca21 (Denning et al, 1995). Of the other isoforms
examined, PKCδ was primarily cytosolic whereas PKCε was primarily
particulate (Fig 3). Interestingly, there was a reduction in the abundance
Figure 4. Density-mediated expression of keratinocyte differentiation
markers is blocked by inhibiting the PKC pathway. Treatment with the
indicated concentrations of bryostatin 1 or GF 109203X (GF) was initiated
when cultures were preconfluent. Cells were grown for 96 h, until postconfluent,
in the presence of inhibitors. Total cell lysates were prepared and immunoblotting
performed as in Fig 1. Note the selective inhibition of all granular cell
differentiation markers examined, but not keratins K1 and K14.
of particulate PKCε in confluent and postconfluent cultures (Fig 3).
PKCη remained evenly distributed among each compartment in the
differing states of confluency. It is unlikely that the appearance of
PKCα in the particulate fraction of differentiating keratinocytes was
an artifact related to protein cross-linking, as neither PKCδ nor
PKCη exhibited convincing evidence of retention in this cellular
fraction (Fig 3).
Inhibition of PKC blocks cell density-mediated keratinocyte
differentiation The foregoing studies demonstrated a temporal
correlation between induction of human keratinocyte differentiation
by confluency and the activation of PKCα. To provide more direct
evidence for the causal role of PKC activation in the differentiation
response, specific inhibitors of PKC that work by different mechanisms
were employed. These had previously been used to evaluate PKC-
mediated events in mouse keratinocyte cultures. Bryostatin 1 is a
natural product with a high affinity for binding to PKC (Pettit, 1991),
that transiently activates PKC but subsequently causes downregulation
in an isoform-specific manner (Szallasi et al, 1994; Denning et al, 1995).
Bryostatin 1 inhibited expression of granular cell markers in both adult
and neonatal confluent keratinocytes at doses of 0.1–1 nM, but did
not inhibit expression of K1 or K14, suggesting that PKC is less
important in cell density-mediated regulation of basal or spinous cell
markers (Fig 4). Another specific inhibitor of PKC is GF 109203X,
which competes at the ATP binding site (Toullec et al, 1991). GF
109203X also effectively inhibits granular cell differentiation marker
expression at both 1 and 5 µM concentrations (Fig 4). Like bryostatin
1, GF109203X did not alter expression of K1 or K14. Neither PKC
inhibitor was toxic to keratinocytes, because total cell number was not
reduced in treated cultures when compared with untreated controls
after a 96 h exposure (data not shown). These data also indicate that
the inhibitory effect of PKC inhibitors on keratinocyte differentiation
was not due to growth suppression and a resultant reduction in
cell density.
DISCUSSION
The results reported here suggest that PKC activation is required for
the expression of granular cell differentiation markers in cultured
human keratinocytes, independent of changes in extracellular Ca21.
Previous studies had shown that both PKC activity (Gherzi et al, 1992;
Matsui et al, 1992) and ligand binding (Snoek et al, 1987) increased in
human keratinocytes induced to differentiate by raising extracellular
Ca21. Because the spinous cell marker K1 does not require PKC
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activation for expression, we conclude that PKC regulates the spinous
to granular transition in human keratinocytes induced to differentiate
by confluency, as we have shown previously for mouse keratinocytes
induced by Ca21 (Dlugosz and Yuspa, 1993, 1994). Although our
study only examined marker expression at the protein level, it is likely
that PKC is regulating differentiation by influencing gene expression,
because prior studies designed to examine this relationship indicate
that differentiation markers are controlled at the transcriptional level
(Dlugosz and Yuspa, 1993). Of relevance to this issue is a previous
study demonstrating upregulation of loricrin mRNA expression in
postconfluent human keratinocyte cultures (Hohl et al, 1991). This
report also confirmed that the changes in loricrin gene expression were
due to confluency status, rather than the amount of time during which
the cells were kept in culture.
One downstream target for PKC action could be the AP-1 transcrip-
tion factor family that is known to be a target for PKC in keratinocytes
and is a component of the regulatory region of genes for the granular
cell markers that we have studied (Rutberg et al, 1996). Other studies
have employed exogenous activators of PKC and cultured human
keratinocytes to demonstrate a role for PKC in expression of collagenase
(Sudbeck et al, 1994), cytochrome p-4501 A1 (Berghard et al, 1993),
ornithine decarboxylase (Verma et al, 1985), and involucrin (Jones and
Sharpe, 1994), and a selective role for PKCη in the induction of
transglutaminase gene expression (Ueda et al, 1996).
Although the activation of PKC during keratinocyte differentiation
has been demonstrated in several reports, we observed only minor
changes in the total levels of PKC isozymes, although the redistribution
of PKCα is taken as an indication of this isozyme’s activation. This
differs from several previous reports in which differentiation was
induced by Ca21 or stratification and increases in PKC mRNA or
protein were detected (Gherzi et al, 1992; Matsui et al, 1992), suggesting
that confluency may involve a change in intracellular activators of
PKC. Both diacylglycerol and cholesterol sulfate are known to increase
in differentiating human keratinocytes (Jetten et al, 1989), and conflu-
ency is associated with a rise in intracellular Ca21 (Pillai et al, 1991).
Furthermore, exogenous phospholipase C can mimic the effects of
phorbol esters on cultured human keratinocytes and induce
cornification (Parkinson, 1987), confirming that upregulation of diacyl-
glycerol can activate PKC in keratinocytes.
The elucidation of the signaling pathways that regulate epidermal
differentiation is important for understanding the pathophysiology of
skin disease and for designing pharmaceuticals for rational therapies.
In particular, the PKC pathway appears to be impacted in psoriasis,
where the enzyme activity levels and distribution are altered, presumably
as a consequence of overactivity of phospholipase C and elevation of
diacylglycerol (Horn et al, 1987; Fisher et al, 1990, 1993; Koizumi
et al, 1993; Rasmussen and Celis, 1993). Such a change might be
expected to alter the onset of terminal differentiation, and this is
consistent with the pathology of that disease. Although the precise
isoforms involved in this change are not clearly defined and some
overlap in function may be expected, advances in drug design or
molecular approaches to cutaneous therapies may provide clinicians
with specific drugs to inhibit PKC isoforms and to modify signaling
in this pathway.
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